Deposition of fenoterol from pressurized metered dose inhalers containing hydrofluoroalkanes

Journal of Allergy and Clinical Immunology

Volumn 104, Issue 6, 1999, Pages

  Newman, Stephen P ^a   Pitcaim, Gary ^a   Steed, Karen ^a   Harrison, Aleck ^b   Nagel, Jürgen ^c  

^a PHARMACEUTICAL PROFILES LTD   (United Kingdom)

^b BOEHRINGER INGELHEIM LTD   (United Kingdom)

^c BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

Asthma therapy; Bronchodilators; Drug deposition; Pressurized metered dose inhaler

Indexed keywords

CHLOROFLUOROCARBON; FENOTEROL; FENOTEROL PLUS IPRATROPIUM BROMIDE; FLUORINATED HYDROCARBON;

AEROSOL; ARTICLE; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG DISTRIBUTION; DRUG FORMULATION; HUMAN; HUMAN EXPERIMENT; INHALATIONAL DRUG ADMINISTRATION; LUNG; MALE; METERED DOSE INHALER; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0033407085     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0091-6749(99)70042-4     Document Type: Article

References (21)

1. 1. Partridge MR, Woodcock AA, Sheffer AL. Wanner A, Rubinfeld A. Chlorofluorocarbon-free inhalers: Are we ready for the change? Eur Respir J 1998;11:1006-8.
2. 2. Smith IJ. The challenge of reformulation. J Aerosol Med 1995;8.S19-S27.
3. 3. Leach CL. Improved delivery of inhaled steroids to the large and small airways. Respir Med 1998;92(suppl):3-8.
4. 4. Leach CL, Davidson PJ, Boudreau RJ. Improved airway targeting with the CFC-free HFA-beclomethasone metered dose inhaler compared with CFC-beclomethasone. Eur Respir J 1998;12:1346-53.
5. 5. Steed KP, Hooper G, Brickwell J, Newman SP The oropharyngeal and lung deposition patterns of a fusafungine MDI spray delivered by HFA 134a propellant or by CFC 12 propellant. Int J Pharm 1995;123:291-3.
6. 6. Newman SP, Richards JC, Pitcairn GR, Rohatagi S, Gillen MS. Improved lung targeting of a novel HFA-based formulation of triamcinolone acetonide delivered by pressurised metered dose inhaler [abstract]. Pharm Sci 1998;1:S-209.
7. 7. Richards JC. Pitcairn GR, Sista S, Mahashabde S, Abramowitz W, Newman SP. A scintigraphic study to assess the deposition of flunisolide delivered by HFA and CFC metered dose inhalers. In: Dalby RN, Byron PR, Farr SJ, editors. Respiratory drug delivery VI. Buffalo Grove. Ill: Interpharm Press; 1998. p. 405-6.
8. 8. Newman SP. Scintigraphic assessment of therapeutic aerosols. Crit Rev Ther Drug Carrier Syst 1993;10:65-109.
9. 9. Newman SP. Scintigraphic assessment of pulmonary delivery systems. Pharmacol Tech 1998;22:78-94.
10. 10. Newman SP, Clark AR, Talaee N, Clarke SW. Pressurized aerosol deposition in the human lung with and without an "open" spacer. Thorax 1989;44:706-10.
11. 11. Newman SP, Weisz AWB, Talaee N, Clarke SW. Improvement of drug delivery with a breath actuated pressurised aerosol for patients with poor inhaler technique. Thorax 1991;46:712-6.
12. 12. Farr SJ. The physicochemical basis of radiolabelling metered dose inhalers with 99mTc. J Aerosol Med 1996;9(suppl):S27-S36.
13. 13. Newman SP. Characteristics of radiolabelled versus unlabelled formulations. J Aerosol Med 1996;9(suppl):S37-S47.
14. 14. Pitcairn GR, Newman SP. Tissue attenuation corrections in gamma scintigraphy. J Aerosol Med 1997;3:187-98.
15. 15. Newman SP, Hirst PH, Pitcairn GR, Clark AR. Understanding regional lung deposition in gamma scintigraphy. In: Dalby RN, Byron PR. Farr SJ, editors. Respiratory drug delivery VI. Buffalo Grove, Ill: Interpharm Press; 1998. p. 9-15.
16. 16. Polli GP, Grim WM, Bacher FA, Yunker MH. Influence of formulation on aerosol particle size. J Pharmacol Sci 1969;58:484-6.
17. 17. Lewis DA, Johnson S, Meakin BJ, et al. Effects of actuator orifice diameter on beclomethasone dipropionate delivery from a PMDI HFA solution formulation. In: Dalby RN, Byron PR, Farr SJ, editors. Respiratory drug delivery VI. Buffalo Grove, Ill: Interpharm Press; 1998. p. 363-4.
18. 18. Evans AE, Ward S, Prowse K. Respirable fraction and clinical response in relation to orifice size of aerosol inhalers [abstract]. Thorax 1992;47:239P.
19. 19. Dolovich MB, Ruffin R, Corr D, Newhouse MT. Clinical evaluation of a new demand-inhalation MDI aerosol delivery device. Chest 1983;84:36-41.
20. 20. Melchor R, Biddiscombe MF, Mak VHF, Short MD, Spiro SG. Lung deposition patterns of directly labelled salbutamol in normal subjects and in patients with reversible airways obstruction. Thorax 1993;48:506-11.
21. 21. Laube BL, Edwards AM, Dalby RN, Creticos PS, Norman PS. The efficacy of slow versus faster inhalation of cromolyn sodium in protecting against allergen challenge in patients with asthma. J Allergy Clin Immunol 1998;101:475-83.